Anti-hypertensive medications and risk of colorectal cancer: a systematic review and meta-analysis
Author:
Funder
Canadian Cancer Society
Michael Smith Foundation for Health Research
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10552-022-01570-1.pdf
Reference54 articles.
1. Mills KT, Stefanescu A, He J (2020) The global epidemiology of hypertension. Nat Rev Nephrol 16:223–237. https://doi.org/10.1038/s41581-019-0244-2
2. Nerenberg KA, Zarnke KB, Leung AA et al (2018) Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children. Can J Cardiol 34:506–525. https://doi.org/10.1016/j.cjca.2018.02.022
3. Ni H, Rui Q, Zhu X, Yu Z, Gao R, Liu H (2017) Antihypertensive drug use and breast cancer risk: a meta-analysis of observational studies. Oncotarget 8:62545
4. Assimes TL, Elstein E, Langleben A, Suissa S (2008) Long-term use of antihypertensive drugs and risk of cancer. Pharmacoepidemiol Drug Saf 17:1039–1049. https://doi.org/10.1002/pds.1656
5. Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term exposure to antihypertensive drugs and the risk of cancer occurrence: evidence from a large population-based study;Journal of Hypertension;2024-08-14
2. Advanced progress of the relationship between renin–angiotensin–aldosterone system inhibitors and cancers;Journal of Hypertension;2024-08-08
3. Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence;European Heart Journal;2024-03-05
4. Antihypertensive medications and risk of colorectal cancer in British Columbia;Frontiers in Pharmacology;2023-11-07
5. Targeting beta-catenin signaling for prevention of colorectal cancer – Nutraceutical, drug, and dietary options;European Journal of Pharmacology;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3